The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.50
Bid: 110.00
Ask: 115.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.545%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights & Share Capital

1 Oct 2021 08:47

RNS Number : 7127N
Eco Animal Health Group PLC
01 October 2021
 

1 October 2021

 

 

ECO Animal Health Group PLC

 

Total Voting Rights and Share Capital

 

 

ECO Animal Health Group PLC (the "Company") announces that, as at 30 September 2021, the issued share capital of the Company consisted of 67,721,916 ordinary shares of 5 pence each with voting rights ("Ordinary Shares"). No Ordinary Shares are currently held in treasury and the voting rights of all the Ordinary Shares are identical.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information, please contact:

 

 

ECO Animal Health Group plc

Marc Loomes (CEO)

Christopher Wilks (CFO)

 

020 8447 8899

 

IFC Advisory

Graham Herring

Zach Cohen

 

020 3934 6630

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Mark Taylor

George Tzimas

 

020 7496 3000

Peel Hunt LLP (Joint Broker)

James Steel

Dr Christopher Golden

020 7418 8900

 

 

 

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development for new products, particularly vaccines, and seeking to in-license new products.

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRDFLBBFBLZFBZ
Date   Source Headline
7th Mar 200611:47 amRNSSAR 3 - Lawrence Plc
13th Feb 20067:01 amRNSTrading Statement
26th Jan 200611:47 amRNSSAR 3 - Lawrence Plc
12th Dec 20057:01 amRNSInterim Results
23rd Nov 200512:58 pmRNSSAR 3 - Lawrence Plc
27th Oct 200510:56 amRNSSAR 3 - Lawrence Plc
5th Sep 200510:52 amRNSSAR 3 - Lawrence Plc
29th Jul 20057:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.